Aardvark Therapeutics, Inc. (AARD)
3.76
-0.02
(-0.53%)
USD |
NASDAQ |
Oct 19, 16:00
3.81
+0.05
(+1.33%)
After-Hours: 20:00
Aardvark Therapeutics Price to Book Value : 1.100 for Oct. 19, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 16, 2026 | 1.106 |
| October 15, 2026 | 1.129 |
| October 14, 2026 | 1.135 |
| October 13, 2026 | 1.182 |
| October 12, 2026 | 1.302 |
| October 09, 2026 | 1.393 |
| October 08, 2026 | 1.378 |
| October 07, 2026 | 1.451 |
| October 06, 2026 | 1.475 |
| October 05, 2026 | 1.527 |
| October 02, 2026 | 1.46 |
| October 01, 2026 | 1.542 |
| September 30, 2026 | 1.542 |
| September 29, 2026 | 1.565 |
| September 28, 2026 | 1.542 |
| September 25, 2026 | 1.480 |
| September 24, 2026 | 1.624 |
| September 23, 2026 | 1.627 |
| September 22, 2026 | 1.682 |
| September 21, 2026 | 1.630 |
| September 18, 2026 | 1.574 |
| September 17, 2026 | 1.618 |
| September 16, 2026 | 1.507 |
| September 15, 2026 | 1.469 |
| September 14, 2026 | 1.624 |
| Date | Value |
|---|---|
| September 11, 2026 | 1.501 |
| September 10, 2026 | 1.466 |
| September 09, 2026 | 1.440 |
| September 08, 2026 | 1.560 |
| September 04, 2026 | 1.574 |
| September 03, 2026 | 1.676 |
| September 02, 2026 | 1.741 |
| September 01, 2026 | 1.732 |
| August 31, 2026 | 1.785 |
| August 28, 2026 | 1.694 |
| August 27, 2026 | 1.937 |
| August 26, 2026 | 1.992 |
| August 25, 2026 | 2.121 |
| August 24, 2026 | 2.013 |
| August 21, 2026 | 1.995 |
| August 20, 2026 | 1.723 |
| August 19, 2026 | 1.975 |
| August 18, 2026 | 1.798 |
| August 17, 2026 | 1.972 |
| August 14, 2026 | 1.914 |
| August 13, 2026 | 1.875 |
| August 12, 2026 | 1.922 |
| August 11, 2026 | 2.104 |
| August 10, 2026 | 2.212 |
| August 07, 2026 | 2.311 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.792 |
| Corcept Therapeutics, Inc. | 17.13 |
| Veru, Inc. | 1.385 |
| Johnson & Johnson | 7.200 |
| Eli Lilly & Co. | 34.48 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0131 |
| Price | 3.76 |
| Earnings Yield | -85.24% |
| Market Cap | 82.28M |
| PEGY Ratio | -0.0131 |